EXPERIENCE

Chris’s areas of expertise include merger enforcement, interlocking directorates, joint ventures, compliance programs, and employee “no-poach” agreements. He has advised on cross-border investigations involving the European Union, the United Kingdom, Canada, Brazil, Japan, Korea and Saudi Arabia, among other jurisdictions, and has handled merger reviews and other antitrust matters involving multiple industries, including health insurance, transportation, telecommunications, technology, energy, agriculture and biotechnology.

Prior to his private practice, Chris was a trial attorney in the Transportation, Energy & Agriculture Section of the U.S. Department of Justice’s Antitrust Division. During his time in the Division, he managed or played a key role in numerous high-profile matters, including merger reviews for Halliburton-Baker Hughes, Aetna-Humana, Anthem-Cigna, Alaska Airlines-Virgin and CVS-Aetna. Chris received the Antitrust Division’s Award of Distinction on two separate occasions.

Chris’s notable representations include:

• Pioneer Natural Resources in its acquisition by ExxonMobil;
• Platinum Equity in its acquisition of Solenis;
• GE Healthcare in its acquisition of BK Medical;
• Xylem in its acquisition of Evoqua;
• Spark Therapeutics in its acquisition by Roche; and
• Stone Canyon Industries in its acquisition of Morton Salt

PROFESSIONAL AFFILIATIONS AND THOUGHT LEADERSHIP

Chris is active in the ABA’s Antitrust Section, and frequently writes and speaks on antitrust topics. A Vice Chair of the ABA Antitrust Section’s Transportation & Energy Industries Committee, and member of the Section’s Health Care and Pharmaceuticals Committee, he is a frequent participant in ABA webcasts and presentations, and an editor the American Bar Association’s Antitrust Health Care Chronicle and Antitrust Laws & Trade Regulation: Desk Edition. And has been published innumerous antitrust newsletters and publications.

While at Columbia Law School, Chris was a Harlan Fiske Stone scholar and served as an editor on the Columbia Business Law Review.